Crocin's role in modulating MMP2/TIMP1 and mitigating hypoxia-induced pulmonary hypertension in mice

Jing Deng,Rui-Qi Wei,Wen-Mei Zhang,Chang-Yu Shi,Rui Yang,Ming Jin,Chunmei Piao

DOI: https://doi.org/10.1038/s41598-024-62900-8

IF: 4.6

2024-06-05

Scientific Reports

Abstract:To explore the molecular pathogenesis of pulmonary arterial hypertension (PAH) and identify potential therapeutic targets, we performed transcriptome sequencing of lung tissue from mice with hypoxia-induced pulmonary hypertension. Our Gene Ontology analysis revealed that "extracellular matrix organization" ranked high in the biological process category, and matrix metallopeptidases (MMPs) and other proteases also played important roles in it. Moreover, compared with those in the normoxia group, we confirmed that MMP s expression was upregulated in the hypoxia group, while the hub gene Timp1 was downregulated. Crocin, a natural MMP inhibitor, was found to reduce inflammation, decrease MMPs levels, increase Timp1 expression levels, and attenuate hypoxia-induced pulmonary hypertension in mice. In addition, analysis of the cell distribution of MMPs and Timp1 in the human lung cell atlas using single-cell RNAseq datasets revealed that MMPs and Timp1 are mainly expressed in a population of fibroblasts. Moreover, in vitro experiments revealed that crocin significantly inhibited myofibroblast proliferation, migration, and extracellular matrix deposition. Furthermore, we demonstrated that crocin inhibited TGF-β1-induced fibroblast activation and regulated the pulmonary arterial fibroblast MMP2/TIMP1 balance by inhibiting the TGF-β1/Smad3 signaling pathway. In summary, our results indicate that crocin attenuates hypoxia-induced pulmonary hypertension in mice by inhibiting TGF-β1-induced myofibroblast activation.

multidisciplinary sciences

What problem does this paper attempt to address?

The paper aims to explore the molecular pathogenesis of pulmonary arterial hypertension (PAH) and identify potential therapeutic targets. Specifically, the study analyzed the lung tissue of mice under hypoxia-induced pulmonary hypertension (HPH) conditions through transcriptome sequencing and found that extracellular matrix (ECM) organization plays a significant role in the biological process, with matrix metalloproteinases (MMPs) and other proteases playing crucial roles. Compared to the normoxia group, the expression of MMPs was upregulated in the hypoxia group, while the expression of the core gene TIMP1 was downregulated. The study also found that crocin, a natural MMP inhibitor, can reduce inflammation, lower MMP levels, increase TIMP1 expression, and alleviate hypoxia-induced pulmonary hypertension in mice. Additionally, single-cell RNA sequencing analysis of the human lung cell atlas revealed that MMPs and TIMP1 are primarily expressed in fibroblasts. In vitro experiments showed that crocin significantly inhibited the proliferation, migration, and ECM deposition of myofibroblasts and regulated the MMP2/TIMP1 balance in pulmonary artery fibroblasts by inhibiting the TGF-β1/Smad3 signaling pathway. In summary, the research results indicate that crocin alleviates hypoxia-induced pulmonary hypertension in mice by inhibiting TGF-β1-induced myofibroblast activation. This finding provides new insights and potential drug targets for the treatment of pulmonary arterial hypertension.

Crocin's role in modulating MMP2/TIMP1 and mitigating hypoxia-induced pulmonary hypertension in mice

Suppression of Tissue Inhibitors of Metalloproteinases May Reverse Severe Pulmonary Arterial Hypertension.

Inhibition of CXCR4 ameliorates hypoxia-induced pulmonary arterial hypertension in rats.

Activity of Matrix Metalloproteinase in Airway Epithelial Cells of COPD Patients.

Vascular Endothelial Cell-Specific Connective Tissue Growth Factor (CTGF) Is Necessary for Development of Chronic Hypoxia-Induced Pulmonary Hypertension

Angiotensin-converting Enzyme Defines Matrikine-Regulated Inflammation and Fibrosis

Ginsenoside Rg1 alleviates vascular remodeling in hypoxia-induced pulmonary hypertension mice through the calpain-1/STAT3 signaling pathway

Ginsenoside Rg1 ameliorates hypoxia-induced pulmonary arterial hypertension by inhibiting endothelial-to-mesenchymal transition and inflammation by regulating CCN1

Metabolic Reprogramming Regulates the Proliferative and Inflammatory Phenotype of Adventitial Fibroblasts in Pulmonary Hypertension Through the Transcriptional Corepressor C-Terminal Binding Protein-1

Effect of Hypoxia on Stimulatory Effect of TGF-β1 on MMP-2 and MMP-9 Activities in Mouse Fibroblasts

Human pulmonary artery smooth muscle cell dysfunction is regulated by miR-509-5p in hypoxic environment

Paeoniflorin attenuates monocrotaline-induced pulmonary arterial hypertension in rats by suppressing TAK1-MAPK/NF-kappa B pathways

[The Changes of Expression Level of Matrix Metalloprotease 9 and Its Inhibitor (TIMP-1) in Murine Pulmonary Fibrosis Model].

Paeoniflorin attenuates monocrotaline-induced pulmonary arterial hypertension in rats by suppressing TAK1-MAPK/NF-κB pathways

Serum–Glucocorticoid Regulated Kinase 1 Regulates Macrophage Recruitment and Activation Contributing to Monocrotaline-Induced Pulmonary Arterial Hypertension

Transcriptomic profiling highlights cell proliferation in the progression of experimental pulmonary hypertension in rats

Alleviating experimental pulmonary hypertension<i> via</i> co-delivering FoxO1 stimulus and apoptosis activator to hyperproliferating pulmonary arteries

CircST6GAL1 knockdown alleviates pulmonary arterial hypertension by regulating miR‐509‐5p/multiple C2 and transmembrane domain containing 2 axis

Crosstalk between the Akt/mTORC1 and NF-κB signaling pathways promotes hypoxia-induced pulmonary hypertension by increasing DPP4 expression in PASMCs

Effects of Endogenous Carbon Monoxide on Collagen Synthesis in Pulmonary Artery in Rats under Hypoxia.

A micropeptide MSTRG.1695.1-aa alleviates inflammatory-fibrosis pathological injury of lung tissue in COPD mice by suppressing EMT via targeting p38-MAPK